berberine glp 1 compounds improves hyperglycemia via microbiome mediated colonic TGR5-GLP pathway in db/db mice GLP-1 Support + Triphala Colon
Description
By Drug Type: Prescription Dominance Reinforced by Payer Mandates Prescription products represented 64.53% of the anti-obesity drugs market in 2025, and the cohort is on track for a 32.85% CAGR through 2031
the early weeks are about earning tolerance, not about results
BMC Cardiovasc
Pre-clinical studies showed that anti-atherogenic effect of GLP-1 is independent of modulation of plasma lipid levels and depends on anti-inflammatory response
If improvement is minimal, add bismuth subsalicylate (Pepto-Bismol) after meals and consider discussing slower dose titration with your provider
